LRIG3 Antikörper
-
- Target Alle LRIG3 Antikörper anzeigen
- LRIG3 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser LRIG3 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- Antigen affinity purification
- Immunogen
- Synthetic peptide of Human LRIG3
- Isotyp
- IgG
- Top Product
- Discover our top product LRIG3 Primärantikörper
-
-
- Applikationshinweise
- ELISA:1:1000-1:5000, IHC:1:25-1:100,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- -20 °C, pH 7.4 PBS, 0.05 % Sodium azide, 40 % Glycerol
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- LRIG3 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 3 (LRIG3))
- Andere Bezeichnung
- LRIG3 (LRIG3 Produkte)
- Synonyme
- LRIG3 antikoerper, lrig3 antikoerper, GB17149 antikoerper, LIG3 antikoerper, 9030421L11Rik antikoerper, 9130004I02Rik antikoerper, 9430095K15Rik antikoerper, mKIAA3016 antikoerper, RGD1561255 antikoerper, leucine rich repeats and immunoglobulin like domains 3 antikoerper, leucine-rich repeats and immunoglobulin-like domains 3 antikoerper, leucine-rich repeats and immunoglobulin-like domains protein 3 antikoerper, leucine-rich repeats and immunoglobulin like domains 3 S homeolog antikoerper, leucine-rich repeats and immunoglobulin like domains 3 antikoerper, LRIG3 antikoerper, lrig3 antikoerper, LOC726128 antikoerper, lrig3.S antikoerper, Lrig3 antikoerper
- Hintergrund
-
Background: Leucine-rich repeats and immunoglobulin-like domains 3 (Lrig3) was identified by microarray analysis among genes that show differential expression during gastrulation in Xenopus laevis. Lrig3 was expressed in the neural plate and neural crest (NC) at neurula stages, and in NC derivatives and other dorsal structures during tailbud stages. A prominent consequence of the morpholino-induced inhibition of Lrig3 expression was impaired NC formation, as revealed by the suppression of marker genes, including Slug, Sox9 and Foxd3.
Aliases: Leucine-rich repeats and immunoglobulin-like domains protein 3 antibody, Leucine-rich repeats- and immunoglobulin-like domains- containing protein 3 antibody, LIG-3 antibody, LIG3 antibody, LRIG1-3 antibody, Lrig3 antibody, LRIG3_HUMAN antibody
- UniProt
- Q6UXM1
-